NeoRx signs supply deal with Cordis

Article

Monoclonal antibody developerNeoRx of Seattle has signed an agreement with catheter maker Cordisof Miami in which Cordis will supply its Micro-Infusion Catheter(MIC) for use with NeoRx's Biostent anti-restenosis product underdevelopment. The MIC will be

Monoclonal antibody developerNeoRx of Seattle has signed an agreement with catheter maker Cordisof Miami in which Cordis will supply its Micro-Infusion Catheter(MIC) for use with NeoRx's Biostent anti-restenosis product underdevelopment. The MIC will be used to deliver Biostent immediatelyafter balloon angioplasty.

Related Videos
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Emerging Innovations in Molecular Imaging
Related Content
© 2023 MJH Life Sciences

All rights reserved.